dbACP: A Comprehensive Database of Anti-Cancer Peptides

27 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp07054 Temporin-PKE FLPLIIGALSSLLPKIF skin secretion of Pelophylax kl. esculentus Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 17.40 μM
dbacp07059 Temporin-PKE-2K FLPLIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 2.78 μM
dbacp07064 Temporin-PKE-K12 FLPLIIGALSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 24.03 μM
dbacp07069 Temporin-PKE-3K FLPKIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 3.29 μM
dbacp07074 Temporin-PKE-4K FLPKIIGKLSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 27.76 μM
dbacp07079 Temporin-PKE-i FLPLIIGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 2.94 μM
dbacp07084 Temporin-PKE-3i FLPLiiGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 71.18 μM
dbacp07107 Nigrocin-M1 GLLGKILGAGKKVLLGVSGLL Synthetic Membrane disruption mediates selective cytotoxicity. MTT assay H-157 Non-small cell lung cancer IC50 = 24 μM
dbacp07261 t-DPH1-K4 GLWKKIKNVAAAAGKAALGAL Analogue of t-DPH1 Membrane disruption induces apoptotic signaling. MTT assay H-157 Lung Cancer IC50 = 6.143 μM
dbacp07265 t-DPH1-5K GLWKKIKNVAKAAGKAALGAL Analogue of t-DPH1 Membrane disruption induces apoptotic signaling. MTT assay H-157 Lung Cancer IC50 = 1.546 μM
dbacp07269 t-DPH1-6K GLWKKIKNVAKAAGKAAKGAL Analogue of t-DPH1 Membrane disruption induces apoptotic signaling. MTT assay H-157 Lung Cancer IC50 = 88.28 μM
dbacp07273 t-DPH1-6KW WLWKKIKNVAKAAGKAAKGAL Analogue of t-DPH1 Membrane disruption induces apoptotic signaling. MTT assay H-157 Lung Cancer IC50 = 427.3 μM
dbacp07337 Temporin-HLa FFPLIFGALSSILPKIL Hylarana latouchii Membrane disruption MTT assay H-157 Lung Cancer IC50 = 15.18 ± 2.98 μM
dbacp07409 Dermaseptin-TO ALWKDLLKNVGIAAGKAALNKVTDMVNQ Phyllomedusa tomopterna Membrane disruption induces cell death MTT assay H-157 Lung Cancer Graph Figure-7
dbacp07503 Brevinin-1Ha FALGAVTCLIRTKCKVLPKLF Analogue of Brevinin-1H α-helix enhances antimicrobial, anticancer activity MTT assay H-157 Lung Cancer IC50 = 278.9 µM
dbacp07507 Brevinin-1HY FALGAVTKVLYKLFCLITRKC Analogue of Brevinin-1H α-helix enhances antimicrobial, anticancer activity MTT assay H-157 Lung Cancer IC50 = 2.811 µM
dbacp07512 Dermaseptin-PP ALWKDMLKGIGKLAGKAALGAVKTLV Phyllomedusa palliata Membrane disruption triggers dual apoptosis MTT assay H-157 Lung Cancer IC50 = 1.55 μM
dbacp07516 Dermaseptin-PP ALWKDMLKGIGKLAGKAALGAVKTLV Phyllomedusa palliata Membrane disruption triggers dual apoptosis LDH leakage assay H-157 Lung Cancer 80% LDH release at 10−4 M
dbacp07851 Dermaseptin-PT9 GLWSKIKDAAKTAGKAALGFVNEMV Phyllomedusa tarsius Membrane disruption and cationic enhancement MTT assay H-157 Lung Cancer IC50 = 25.51 µM
dbacp07856 K8, 23-DPT9 GLWSKIKKAAKTAGKAALGFVNKMV Synthetic Membrane disruption and cationic enhancement MTT assay H-157 Lung Cancer IC50 = 9.88 µM
dbacp07952 S-24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Synthetic Analogue of Ranatuerin-2PLx R2PLx induces caspase-dependent apoptosis MTT assay H-157 Lung Cancer IC50 = 58.18 µM
dbacp07956 DP-2 GRKKRRQRRRGALWKSLLKNVGKA Synthetic DRS-DU-1 induces selective tumor cytotoxicity MTT assay H-157 Lung Cancer IC50 = 3.21 μM
dbacp07989 K5, 17-DPS3 ALWKKILKNAGKAALNKINQIVQ Analogue of Dermaseptin-PS3 Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay H-157 Lung Cancer IC50 = 18.20 μM
dbacp07991 L10, 11-DPS3 ALWKDILKNLLKAALNEINQIVQ Analogue of Dermaseptin-PS3 Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay H-157 Lung Cancer IC50 = 0.12 μM
dbacp08064 Temporin-PE FLPIVAKLLSGLL Pelophylax kl. esculentus Modulates membrane interactions MTT assay NCI-H-157 Lung Cancer IC50 = 34.56 μM
dbacp08068 temporin-PEa FLYIVAKLLSGLL Synthetic analog of Temporin-PE Modulates membrane interactions MTT assay NCI-H-157 Lung Cancer IC50 = 3.398 μM
dbacp08072 temporin-PEb FLPIVAKLLSGLLGRKKRRQRRR Synthetic analog of Temporin-PE Modulates membrane interactions MTT assay NCI-H-157 Lung Cancer IC50 = 3.464 μM